Panuveitis and Netra Restoration Therapy

A Whole-Eye Inflammatory Condition That Requires a Multi-Factorial View

From an integrative ophthalmology perspective, panuveitis is not simply an isolated inflammatory event. It is often a manifestation of deeper biological instability: immune overactivity, loss of ocular immune privilege, disruption of the blood-ocular and blood-retinal barriers, oxidative stress, altered vascular permeability, mitochondrial injury, neuroretinal vulnerability, and systemic inflammatory burden. These interacting mechanisms are why a single-factor view of panuveitis can feel incomplete to many patients. The visible inflammation inside the eye is only one part of the story; the underlying terrain that allows inflammation to ignite, persist, recur, or leave visual dysfunction behind is equally important.

Netra Eye Institute approaches panuveitis through this broader biological lens. Netra Restoration Therapy, or NRT, is designed as a comprehensive supportive program for patients whose eyes have been affected by inflammatory, vascular, metabolic, neuroimmune, and degenerative stress. The goal is not to ignore the seriousness of active inflammation, nor to replace ongoing ophthalmic supervision. The goal is to strengthen the biological terrain around the eye so that recovery, visual resilience, and long-term ocular stability can be supported from multiple directions.

For website visitors, it is important to state this clearly: panuveitis can be sight-threatening and can have infectious, autoimmune, systemic inflammatory, traumatic, medication-associated, or idiopathic causes. Any new or active episode should be evaluated promptly by an eye-care professional. NRT is best framed as an integrative, restorative support strategy that works alongside appropriate medical oversight while focusing on the biological drivers that conventional diagnostic labels may not fully address in day-to-day patient experience.

A Comprehensive Therapy Designed to Support the Key Underlying Drivers of Panuveitis

Netra Restoration Therapy is a structured, integrative eye-care program created for complex eye conditions in which the health of ocular tissues depends on more than one variable. In panuveitis, the eye is exposed to inflammatory mediators, vascular leakage, immune-cell infiltration, oxidative stress, photoreceptor stress, retinal pigment epithelium strain, choroidal circulation disturbance, and nervous-system sensitization. These mechanisms rarely occur in isolation. They interact in loops: inflammation damages the barrier, barrier breakdown permits more immune trafficking, immune activity increases oxidative stress, oxidative stress injures mitochondria, and mitochondrial dysfunction reduces the energy available for retinal repair and visual signaling.

NRT is designed to support this interlocking network. The program emphasizes ocular microcirculation, neuroimmune modulation, mitochondrial and antioxidant capacity, autonomic regulation, metabolic nourishment, and restoration of the ocular surface and visual system. This is especially relevant in panuveitis because the condition can affect the entire eye ecosystem, from the iris and ciliary body to the vitreous, retina, choroid, macula, retinal vessels, and optic nerve.

The NRT perspective asks a different set of questions: Why is the eye's inflammatory threshold low? Why is the retinal barrier vulnerable? Why are floaters, light sensitivity, visual fatigue, or contrast problems persisting after the most obvious inflammatory signs quiet down? Why does one patient recover visual function more completely than another? Why do some eyes relapse more easily? These questions require attention to terrain, not just inflammation as a visible event.

For panuveitis, NRT is positioned around five core pillars. First, the inflammatory terrain must be calmed and regulated rather than repeatedly provoked. Second, ocular blood flow and microvascular resilience must be supported so that the retina and choroid receive adequate oxygen and nutrient delivery. Third, oxidative and mitochondrial stress must be addressed because inflammatory eyes generate high levels of metabolic demand. Fourth, neuroretinal tissues must be protected from secondary injury, including photoreceptor stress, retinal ganglion cell strain, and optic nerve vulnerability. Fifth, the patient's systemic terrain - sleep, stress physiology, digestion, inflammatory diet patterns, immune triggers, metabolic load, and recovery capacity - must be evaluated as part of the visual picture.

In practical terms, NRT may include acupuncture-based ocular and neurovascular regulation, Ayurvedic and traditional botanical strategies when appropriate, nutritional and metabolic support, lifestyle pattern correction, stress-physiology regulation, visual function support, and careful review of ocular history and imaging. The program is individualized. A patient with autoimmune-associated panuveitis, recurrent idiopathic panuveitis, panuveitis with retinal vasculitis, panuveitis with macular involvement, or panuveitis after systemic inflammatory illness may each need a different terrain strategy.

The purpose of NRT is therefore restorative rather than suppressive in its language. It aims to support the eye's biological capacity to recover from inflammatory stress, preserve visual function, and maintain tissue resilience. This distinction matters for patient trust: panuveitis requires careful diagnosis and monitoring, and NRT should be presented as a complementary, integrative pathway focused on the mechanisms that influence long-term visual outcome.

Why Treatment for Panuveitis Should Be Multi-Factorial

A multi-factorial approach is essential because panuveitis is biologically multi-factorial. It is not merely redness in the front of the eye, haze in the vitreous, or leakage in the retina. It is an inflammatory event occurring inside a highly specialized immune-privileged organ. The eye is designed to preserve optical clarity and protect delicate neural tissue from excessive immune activation. When that balance fails, inflammation can spread across anatomical compartments and disrupt vision in many ways.

The following sub-sections describe the main pathological factors that should be considered when creating a supportive plan for panuveitis. These are not isolated boxes. In a real patient, they overlap. For example, a cytokine flare can increase vascular permeability, which can increase retinal edema, which can impair mitochondrial function in photoreceptors, which can then amplify oxidative stress and visual fatigue. A meaningful integrative plan should therefore be built around networks of physiology rather than a single symptom.

Immune dysregulation and cytokine imbalance

Panuveitis often reflects dysregulated immune signaling inside the eye. T cells, macrophages, microglia, endothelial cells, retinal pigment epithelial cells, and resident ocular immune cells can participate in inflammatory signaling. Cytokines such as IL-6, IL-17, TNF-alpha, IL-1beta, IL-23, and interferon-related pathways may influence immune-cell recruitment, vascular permeability, and tissue injury. A multi-factorial strategy should not describe inflammation as a single substance or one simple pathway. It should recognize that the immune system can become self-amplifying when cytokines, chemokines, barrier disruption, and tissue stress reinforce one another.

Blood-ocular and blood-retinal barrier vulnerability

The eye depends on selective barriers to maintain optical clarity and immune privilege. In panuveitis, these barriers can become more permeable. The result may include inflammatory cells in the anterior chamber, vitreous haze, vascular leakage, retinal swelling, macular stress, or choroidal involvement. Barrier dysfunction is not merely a downstream event; it can perpetuate disease by allowing more immune mediators to reach sensitive tissues. NRT language should therefore include barrier resilience: supporting vascular integrity, microcirculation, and inflammatory control so the eye can return toward a more stable internal environment.

Oxidative stress and free-radical burden

Inflammation increases reactive oxygen and nitrogen species. The retina is already one of the most metabolically active tissues in the body, constantly exposed to oxygen, light, and high energy demand. When intraocular inflammation is present, oxidative stress can damage lipids, proteins, DNA, mitochondria, retinal pigment epithelial cells, photoreceptors, and ganglion cells. This is one reason patients may continue to experience visual fatigue, reduced contrast, or light sensitivity even after the most obvious flare improves. A restorative plan should address antioxidant capacity and redox balance as central components of tissue recovery.

Mitochondrial dysfunction and energy depletion

The retina, optic nerve, and visual pathways require constant ATP production. Inflammatory cytokines, nitric oxide, oxidative stress, hypoxia, and metabolic stress can impair mitochondrial function. Once mitochondria are strained, cells have less capacity to repair, regulate calcium, maintain membrane potentials, and resist apoptosis. This is particularly important for retinal ganglion cells, photoreceptors, and the macular region. NRT therefore emphasizes mitochondrial nourishment, metabolic efficiency, and neuroretinal energy support.

Microcirculation, vascular permeability, and perfusion stress

Panuveitis can involve vascular inflammation, endothelial activation, choroidal congestion, retinal vasculitis-like changes, or perfusion instability. Even when the main clinical label is inflammatory, the downstream visual impact is often vascular and metabolic. Oxygen delivery, capillary stability, lymphatic-like clearance, and venous outflow all influence tissue function. Support for microcirculation is not simply about increasing blood flow; it is about encouraging appropriate, regulated circulation in tissues that are inflamed, vulnerable, and metabolically active.

Neuroretinal and optic nerve vulnerability

Inflammation can affect neural tissue indirectly through cytokines, oxidative stress, edema, ischemic stress, and glial activation. Photoreceptors, bipolar cells, retinal ganglion cells, Muller cells, retinal pigment epithelium, and optic nerve fibers may all be affected by inflammatory terrain. This can lead to visual symptoms that feel disproportionate to a simple description of eye inflammation: dimness, poor contrast, visual fatigue, glare, persistent haze, reduced reading stamina, or delayed recovery after bright light exposure. A multi-factorial plan should include neuroprotection and visual-function restoration as explicit goals.

Systemic inflammatory terrain and immune triggers

Panuveitis can be associated with systemic inflammatory disorders, infections, autoimmune tendencies, gut-immune dysregulation, stress physiology, environmental triggers, or unknown idiopathic patterns. The eye may be the organ where a broader immune imbalance becomes visible. A meaningful integrative intake should therefore explore flare patterns, systemic symptoms, digestion, sleep, stress, diet, immune history, skin and joint symptoms, respiratory history, infection history, and family history of inflammatory disease. This does not replace medical diagnosis; it helps identify terrain factors that may influence resilience.

Autonomic stress physiology and inflammatory threshold

Stress does not 'cause' every case of panuveitis, but autonomic imbalance can influence immune tone, vascular regulation, sleep quality, pain sensitivity, and recovery capacity. Chronic sympathetic activation may worsen inflammatory vulnerability, reduce restorative sleep, and impair tissue repair. Many patients with recurrent inflammatory conditions notice that flares follow periods of exhaustion, infection, emotional stress, poor sleep, or systemic strain. NRT addresses stress physiology as part of the inflammatory terrain, not as a simplistic explanation for the disease.

Ocular surface, photophobia, and sensory sensitivity

Although panuveitis occurs inside the eye, patients may also experience ocular surface discomfort, tearing, dryness, light sensitivity, brow ache, and sensory fatigue. Inflammation can sensitize trigeminal pathways and make normal visual environments feel harsh. Supporting the ocular surface, blink pattern, light adaptation, and nervous-system regulation can help reduce the burden of symptoms while deeper ocular recovery is monitored.

Recurrence patterns and incomplete recovery

A patient may be told that inflammation has quieted, yet still feel that vision is not normal. The reasons can include retinal remodeling, persistent oxidative stress, subtle macular dysfunction, vitreous changes, contrast loss, neural sensitization, or a reduced reserve in the affected eye. A multi-factorial approach asks what remains vulnerable after the flare, and how the eye's recovery capacity can be supported over time.

Key Biological Mechanisms in Panuveitis

The biological mechanisms of panuveitis can be understood as a cascade. The cascade may begin with infection, autoimmunity, systemic inflammatory disease, trauma, molecular mimicry, microbial triggers, genetic susceptibility, environmental exposure, or no clearly identifiable cause. Regardless of the initial trigger, the final common pathway involves intraocular inflammation and tissue stress across multiple ocular compartments.

One of the central mechanisms is the disruption of ocular immune privilege. Under healthy conditions, the eye limits excessive immune activation to preserve transparency and protect neural tissue. In panuveitis, antigen presentation, T-cell activation, innate immune signaling, microglial activation, and cytokine release can overcome those protective mechanisms. Pattern recognition receptors such as toll-like receptors and intracellular inflammasome pathways may amplify the release of inflammatory cytokines. Once activated, resident cells and recruited immune cells create a feedback loop that can maintain inflammation.

The Th1 and Th17 immune axes are frequently discussed in uveitis biology. Th17 cells and IL-17-related signaling are associated with autoimmune and autoinflammatory ocular inflammation. IL-6 can promote Th17 differentiation, endothelial activation, leukocyte recruitment, and blood-retinal barrier stress. TNF-alpha and IL-1beta can amplify cytokine cascades, activate vascular endothelium, and increase the expression of adhesion molecules that allow immune cells to enter ocular tissues. These pathways are important because they explain why panuveitis can spread beyond one anatomical layer and become a whole-eye problem.

A second major mechanism is blood-retinal barrier and blood-ocular barrier breakdown. When the inner retinal barrier, outer retinal barrier, or anterior blood-aqueous barrier becomes compromised, inflammatory proteins, immune cells, and fluid can enter spaces where they do not normally belong. The patient may experience hazy vision from inflammatory cells, floaters from vitreous involvement, blurred central vision from macular stress, or reduced retinal function from leakage and metabolic disturbance. Barrier breakdown is also linked to vascular endothelial activation and changes in cytokine profiles.

A third mechanism is oxidative stress. Inflammation increases reactive oxygen and nitrogen species, while the retina's high metabolic activity makes it vulnerable to oxidative injury. Photoreceptors are especially sensitive because they operate in a light-exposed, oxygen-rich environment with continuous membrane turnover. Retinal pigment epithelial cells must process photoreceptor outer segments while also maintaining barrier and metabolic functions. When inflammation increases oxidative load, these tissues can become overwhelmed.

A fourth mechanism is mitochondrial strain. Mitochondria are central to retinal survival, visual signaling, cellular repair, calcium regulation, and apoptosis control. Inflammatory cytokines and oxidative stress can impair mitochondrial respiration, reduce ATP production, and increase cell vulnerability. This mechanism matters in panuveitis because visual recovery requires energy. If the inflammatory event quiets but mitochondria remain stressed, the patient may still experience dimness, fatigue, glare, or incomplete visual function.

A fifth mechanism is glial and microglial activation. Microglia are immune-surveillance cells in the retina and optic nerve environment. When activated, they can help clear debris and coordinate repair, but chronic or excessive activation can release cytokines, chemokines, nitric oxide, and oxidative molecules that intensify neuroinflammation. Muller glia and retinal pigment epithelial cells also participate in immune and metabolic signaling. In a healthy recovery response, these cells help restore balance; in a dysregulated inflammatory environment, they may contribute to ongoing dysfunction.

A sixth mechanism is neurovascular coupling disturbance. The retina requires tight matching between neural activity and blood supply. Inflammation, vascular leakage, endothelial dysfunction, and oxidative stress can impair this relationship. Patients may notice that vision worsens with fatigue, bright light, prolonged reading, screen use, heat, stress, or systemic illness. These patterns suggest that retinal function is not only an optical issue; it is a metabolic and neurovascular issue.

A seventh mechanism is tissue remodeling after inflammation. Even when a flare is no longer active, the eye may be left with vitreous debris, pigmentary disturbance, macular sensitivity, chorioretinal scarring, optic nerve vulnerability, or altered visual processing. This is why the post-inflammatory phase deserves attention. Restoration is not merely the absence of active inflammation; it is the rebuilding of functional reserve.

What Is Netra Restoration Therapy for Panuveitis?

Netra Restoration Therapy for panuveitis is an integrative supportive care program designed to address the biological environment in which ocular inflammation occurs. It is not a one-size-fits-all protocol. It is built around the patient's inflammatory history, visual symptoms, imaging findings, systemic terrain, constitutional pattern, recovery capacity, and goals for visual function. The program is especially relevant for patients who feel that their eye has not fully recovered after inflammatory episodes, or who want a broader strategy to support ocular resilience while remaining under appropriate medical supervision.

The NRT process begins with a detailed consultation. Patients are encouraged to bring ophthalmology records, OCT reports, fundus photos, fluorescein angiography summaries if available, visual field results, lab history, systemic diagnosis history, medication history, and a timeline of flares. The goal is not to reinterpret medical records outside their proper context, but to understand how the inflammatory pattern has affected the patient's visual function and biological reserve.

A panuveitis patient may describe several layers of symptoms. One layer is active inflammatory discomfort: redness, pain, photophobia, floaters, haze, and blurred vision. Another layer is functional limitation: difficulty reading, trouble with screens, glare sensitivity, reduced night comfort, fatigue with visual work, or a sense that vision is not clear even when the eye chart looks acceptable. A third layer is systemic terrain: fatigue, poor sleep, stress load, inflammatory digestion, joint symptoms, skin issues, hormonal changes, post-viral patterns, or autoimmune history. NRT considers all three layers.

Core NRT modalities may include acupuncture ophthalmology techniques aimed at regulating ocular blood flow, autonomic balance, trigeminal-vascular tone, and neuroimmune signaling. In integrative physiology, acupuncture is often discussed in relation to neuroendocrine-immune regulation, cytokine modulation, blood-flow regulation, and pain/sensory processing. The evidence base for acupuncture in eye disease is still developing, and clinical claims should remain measured. In the NRT framework, acupuncture is used as one part of a broader restorative plan rather than as a standalone cure for panuveitis.

NRT may also include Ayurvedic ophthalmology principles and external ocular nourishment approaches when appropriate for the patient's stage and safety profile. These approaches are framed around ocular surface comfort, lubrication, tissue nourishment, sensory calming, and restoration of local resilience. In panuveitis, any external ocular procedure must be chosen conservatively and should not be used during an unstable acute presentation without proper evaluation. The key point is individualized timing: not every tool is appropriate at every stage.

Botanical and nutritional strategies may be considered to support antioxidant capacity, mitochondrial function, vascular health, and systemic inflammatory balance. In this page's language, herbs and nutrients should not be described as direct substitutes for medical care. They should be described as terrain support: assisting redox balance, nourishing retinal metabolism, supporting immune regulation, and helping the body maintain a less reactive inflammatory state. Any internal botanical strategy should be reviewed for safety, especially in patients with autoimmune disease, pregnancy, liver or kidney disease, anticoagulant use, immune-sensitive conditions, or complex medication regimens.

Lifestyle and recovery coaching is also part of NRT. This includes guidance around sleep regularity, circadian rhythm, inflammatory dietary patterns, hydration, screen pacing, light exposure, stress regulation, breathing practices, gentle movement, and flare journaling. These steps may seem basic, but in chronic inflammatory disease they are often the difference between a fragile system and a resilient one. The visual system is highly energy-dependent; it recovers better when the whole body is not constantly operating in depletion.

Finally, NRT includes monitoring of functional response. Patients may track symptoms such as floaters, photophobia, visual clarity, reading stamina, screen tolerance, glare sensitivity, visual fatigue, contrast, night comfort, and recovery after visual strain. These are not replacements for medical imaging or eye exams. They are patient-centered measures of how the visual system is functioning in daily life. For panuveitis, both clinical signs and patient-reported visual experience matter.

How NRT Supports the Biological Terrain in Panuveitis

The phrase biological terrain is important. It means the internal environment that determines how vulnerable or resilient the eye is in the face of inflammation. Two patients can carry the same diagnosis of panuveitis but have very different outcomes. One may recover quickly after a flare; another may remain visually exhausted for months. One may have obvious systemic autoimmune disease; another may have no clear diagnosis but recurrent inflammatory episodes. One may have macular involvement; another may have more vitreous haze and photophobia. NRT is designed to personalize support around these differences.

Supporting immune homeostasis

NRT aims to support a more balanced immune terrain rather than pushing the body in one direction. The goal is to reduce the tendency toward excessive inflammatory amplification while preserving normal repair and defense. This may involve acupuncture-based neuroimmune regulation, nutritional strategies, botanical support, stress reduction, sleep improvement, and identification of lifestyle patterns that appear to lower or raise the patient's inflammatory threshold.

Supporting blood-ocular barrier resilience

Barrier integrity is central in panuveitis because leakage and immune-cell migration can affect the retina, choroid, vitreous, and anterior chamber. NRT frames barrier support through vascular health, oxidative stress control, endothelial resilience, and reduction of systemic inflammatory load. The patient-facing language can be simple: the eye needs a calm, well-regulated internal environment to maintain clarity and protect delicate tissues.

Supporting ocular microcirculation

The choroid and retina depend on precise microcirculation. Inflammatory eyes may have altered vascular tone, endothelial stress, or congestion-like patterns. NRT seeks to support regulated ocular perfusion, not excessive stimulation. This is why acupuncture, breathing practices, autonomic regulation, and nutritional vascular support can be discussed as part of a larger restorative strategy.

Supporting antioxidant and mitochondrial capacity

Inflamed ocular tissues produce higher oxidative stress and require more energy for recovery. NRT emphasizes antioxidant-rich nutrition, mitochondrial-supportive nutrients when appropriate, balanced blood sugar, adequate protein, restorative sleep, and pacing of visual demand. The clinical message is that retinal recovery is energy-dependent, and energy systems must be supported.

Supporting neuroretinal resilience

Panuveitis can stress the neural retina and optic nerve environment. NRT therefore focuses on visual recovery, contrast support, glare adaptation, screen tolerance, and protection of the retinal and optic nerve terrain. This is especially important for patients who feel that inflammation has left them with persistent sensitivity or reduced visual confidence.

Supporting autonomic and stress regulation

Autonomic dysregulation can influence vascular tone, immune signaling, sleep quality, pain perception, and recovery. NRT may include acupuncture, breathing, relaxation training, movement guidance, and circadian rhythm support. These tools do not imply that panuveitis is psychological. They recognize that immune and vascular systems are regulated through the nervous system.

Supporting digestive and systemic inflammatory balance

Because immune regulation is deeply connected to digestion, metabolism, and systemic inflammation, NRT evaluates the patient's broader terrain. Food sensitivities, blood sugar swings, ultra-processed diets, poor digestion, alcohol burden, dehydration, and chronic sleep debt can all influence inflammatory resilience. A panuveitis page should avoid overpromising diet as a cure, but it can correctly state that systemic inflammatory balance matters for recovery.

Supporting the recovery phase after inflammation

Many patients seek integrative care when active inflammation is quieter but visual function remains compromised. This is where NRT's restorative language is strongest. The goal is to support tissue recovery, visual stamina, light tolerance, clarity, and confidence while maintaining appropriate ophthalmic follow-up. Recovery is not merely about whether inflammation is visible; it is about whether the person can use their vision comfortably in real life.

A Patient-Centered NRT Journey for Panuveitis

A patient with panuveitis often arrives with a long story. They may have seen multiple specialists, received several diagnostic labels, undergone repeated imaging, or been told that the inflammation is quiet while their vision still does not feel normal. Some patients are worried about recurrence. Others are struggling with visual fatigue, photophobia, floaters, haze, or reduced clarity. NRT begins by organizing that story into a coherent map.

The first step is pattern recognition. When did symptoms begin? Was there infection, stress, trauma, travel, systemic illness, vaccination timing, autoimmune flare, digestive change, or medication change around onset? Is the condition unilateral or bilateral? Are flares seasonal, stress-related, infection-related, or idiopathic? Are there systemic signs such as mouth ulcers, skin lesions, joint pain, bowel symptoms, respiratory issues, headaches, neurologic symptoms, or fatigue? These questions help build a terrain profile.

The second step is ocular function mapping. NRT considers not only what the chart says, but how the patient uses vision. Can they read comfortably? Do screens aggravate symptoms? Does bright light create pain or afterimages? Are floaters causing anxiety or reduced contrast? Does vision fluctuate during the day? Does the eye tire faster than before? These details help distinguish inflammation-related discomfort, neuroretinal fatigue, ocular surface contribution, and nervous-system sensitization.

The third step is restorative prioritization. During an unstable flare, the priority is safety, evaluation, and avoiding anything that could worsen irritation. During a quieter phase, the priority may shift toward tissue recovery, circulation, mitochondrial support, autonomic balance, visual stamina, and recurrence terrain. During a maintenance phase, the priority may be building resilience so that the eye and body have better reserve.

The fourth step is tracking change. The best NRT plan uses both subjective and objective information. Patient-reported outcomes may include light sensitivity, floaters, clarity, reading endurance, visual fatigue, glare, screen tolerance, and overall confidence. Objective monitoring remains the role of appropriate eye-care testing, which may include clinical examination and imaging ordered by the patient's eye-care team. The two types of information should complement each other.

Frequently Asked Questions on Panuveitis

Selected References for Scientific Support

• Maghsoudlou P, Epps SJ, Guly CM, Dick AD. Uveitis in Adults: A Review. JAMA. 2025;334(5):419-434. doi:10.1001/jama.2025.4358.
• Duplechain A, Conrady CD, Patel BC, Baker S. Uveitis. StatPearls. Treasure Island (FL): StatPearls Publishing; updated August 8, 2023.
• Tomkins-Netzer O, Niederer R, Greenwood J, Fabian ID, Serlin Y, Friedman A, Lightman S. Mechanisms of blood-retinal barrier disruption related to intraocular inflammation and malignancy. Progress in Retinal and Eye Research. 2024. doi:10.1016/j.preteyeres.2024.101245.
• Weinstein JE, Pepple KL. Cytokines in uveitis. Current Opinion in Ophthalmology. 2018. Available through PubMed Central.
• Yu X, Duan R, Jiang L, Wang T, Li Z, Zhang B, Su W, Lin Y. Interleukin-6 in non-infectious uveitis: Biology, experimental evidence and treatment strategies. Biochemical Pharmacology. 2024;230(Pt 2):116605. doi:10.1016/j.bcp.2024.116605.
• Zhong Z, Su G, Kijlstra A, Yang P. Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis. Progress in Retinal and Eye Research. 2021;80:100866. doi:10.1016/j.preteyeres.2020.100866.
• Han J, et al. The Immunopathogenesis of Uveitis. Frontiers in Medicine. 2026. doi:10.3389/fmed.2026.1717056.
• Jiang Q, et al. TNF-alpha in Uveitis: From Bench to Clinic. Frontiers in Immunology. 2021. Available through PubMed Central.
• Yadav UCS, Kalariya NM, Ramana KV. Emerging role of antioxidants in the protection of uveitis complications. Current Medicinal Chemistry. 2011;18(6):931-942. Available through PubMed Central.
• Nguyen AM, Rao NA. Oxidative photoreceptor cell damage in autoimmune uveitis. Journal of Ophthalmic Inflammation and Infection / related PubMed Central resource. 2010. Available through PubMed Central.
• Chistyakov DV, et al. Targeting oxidative stress and inflammation in the eye. International Journal of Molecular Sciences. 2024. Available through PubMed Central.
• Kang EYC, et al. Role of oxidative stress in ocular diseases associated with retinal ganglion cell degeneration. Antioxidants. 2021. Available through PubMed Central.
• Yang TH, et al. Mitochondria in retinal ganglion cells: unraveling the mechanisms and therapeutic potential. International Journal of Molecular Sciences. 2024. Available through PubMed Central.
• Catalani E, et al. Targeting mitochondrial dysfunction and oxidative stress to preserve retinal ganglion cells. International Journal of Molecular Sciences. 2023. Available through PubMed Central.
• Guo Z, et al. Does acupuncture treatment modulate inflammatory cytokines in rodent models of depression? A systematic review and meta-analysis. Frontiers in Behavioral Neuroscience. 2024. doi:10.3389/fnbeh.2024.1329638.
• Bautista-Hernandez MA, et al. Acupuncture in the treatment of inflammation-related ocular degenerations: a systematic review. Frontiers in Medicine. 2026. doi:10.3389/fmed.2026.1749297. Note: this review found very low-certainty evidence and no conclusive evidence of effectiveness for ocular inflammatory degenerations, so patient-facing claims should remain measured.
• Sun R, et al. Immunological studies on acupuncture and moxibustion: a bibliometric and mechanistic overview. Medicine. 2024.
• Dammak A, et al. Oxidative stress in anterior ocular diseases. Biomedicines. 2023;11(2):292.